Glycobiology

Global Glycomics Market Report 2023: Sector to Reach $3.46 Billion by 2028 at a 15.6% CAGR - ResearchAndMarkets.com

Retrieved on: 
Friday, April 14, 2023

The global glycomics market was valued at US$1.46 billion in 2022 and is expected to grow to US$3.46 billion in 2028.

Key Points: 
  • The global glycomics market was valued at US$1.46 billion in 2022 and is expected to grow to US$3.46 billion in 2028.
  • Hence, increased demand for medications and treatments is propelling the pharmaceutical & biotechnology companies sector in the glycomics market forward.
  • China's glycomics market dominated the Asia Pacific market due to the increasing investment, and funding by pharmaceutical companies for glycomics research.
  • The glycomics market is expanding mainly because of increased glycomics research efforts and increased R&D expenditures by pharmaceutical and biotechnology companies.

Global Glycobiology Market to Surpass US$ 2,700.5 Million by 2027, Says Coherent Market Insights (CMI)

Retrieved on: 
Friday, May 21, 2021

b'According to Coherent Market Insights, the global glycobiology market is estimated to be valued at US$ 1,165.3 million in 2020 and is expected to exhibit a CAGR of 12.8% during the forecast period (2020-2027).\nKey trends in the global glycobiology market include increase in product launches by key companies, which is expected to drive the global glycobiology market growth over the forecast period.

Key Points: 
  • b'According to Coherent Market Insights, the global glycobiology market is estimated to be valued at US$ 1,165.3 million in 2020 and is expected to exhibit a CAGR of 12.8% during the forecast period (2020-2027).\nKey trends in the global glycobiology market include increase in product launches by key companies, which is expected to drive the global glycobiology market growth over the forecast period.
  • For instance, In March 2017, Bruker Corporation announced the launch of its new nuclear magnetic spectroscopy instrument - AVANCE NEO.
  • The new AVANCE NEO has advanced AVANCE III HD by offering even faster control, improved dynamic range, and enhanced flexibility and scalability.\nFurthermore, key players operating in the global glycobiology market are focusing on adoption of inorganic growth strategies to increase their market presence in the global market.
  • For instance, in May 2020, Thermo Fisher Scientific Inc., collaborated with Biognosys, a leading developer of next-generation proteomics solutions.

The NOSTRADAMUS Study: Microvascular Dysfunction in Sepsis

Retrieved on: 
Monday, April 19, 2021

The study, titled "Identification of novel sublingual parameters to analyze and diagnose microvascular dysfunction in sepsis: the NOSTRADAMUS study" was published in Critical Care.

Key Points: 
  • The study, titled "Identification of novel sublingual parameters to analyze and diagnose microvascular dysfunction in sepsis: the NOSTRADAMUS study" was published in Critical Care.
  • "For several years, GlycoCheck has been used globally in groundbreaking research to understand the complex nature of the endothelial glycocalyx.
  • "\nThe study concludes that new important diameter-specific quantification and differentiated analysis of RBC kinetics is a key to understand microvascular dysfunction in sepsis.
  • MVHSdynamic, which has a broad bandwidth to detect micro-vascular (dys-) function, might serve as a valuable tool to detect microvascular impairment in critically ill patients.\nGlycoCheck analyzes glycocalyx, endothelium, and capillary function.

Global $938 Million Glycobiology Market to 2025

Retrieved on: 
Friday, January 15, 2021

The Global Glycobiology Market was valued at USD 938.76 Million and is expected to grow at a doubled digit CAGR of 13.83% during the forecast period.

Key Points: 
  • The Global Glycobiology Market was valued at USD 938.76 Million and is expected to grow at a doubled digit CAGR of 13.83% during the forecast period.
  • The Global Glycobiology Market is driven by the growing prevalence of chronic diseases such as cancer, diabetics, renal diseases, among others, which has increased the demand for personalized medicines.
  • Furthermore, increasing research activities in glycomics, technological advancements and rising government initiatives is also among the major drivers for the Global Glycobiology Market.
  • The Global Glycobiology Market is segmented based on product, application, End-user, company, and region.

Global Glycobiology (Enzymes, Instruments, Reagents and Kits) Market, Competition, Forecast & Opportunities, 2025 - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 14, 2021

The Global Glycobiology Market was valued at USD 938.76 Million and is expected to grow at a doubled digit CAGR of 13.83% during the forecast period.

Key Points: 
  • The Global Glycobiology Market was valued at USD 938.76 Million and is expected to grow at a doubled digit CAGR of 13.83% during the forecast period.
  • The Global Glycobiology Market is driven by the growing prevalence of chronic diseases such as cancer, diabetics, renal diseases, among others, which has increased the demand for personalized medicines.
  • Furthermore, increasing research activities in glycomics, technological advancements and rising government initiatives is also among the major drivers for the Global Glycobiology Market.
  • Based on kits, the glycobiology market is sub-segmented into glycan releasing kit, glycan purification kit, glycan labeling kit, and others.

Insights on the Glycobiology Global Market to 2025 - Featuring Shimadzu, Takara Bio & Waters Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 12, 2020

The Global Glycobiology Market is expected to grow at a formidable rate during the forecast period.

Key Points: 
  • The Global Glycobiology Market is expected to grow at a formidable rate during the forecast period.
  • The Global Glycobiology Market is driven by the growing prevalence of chronic diseases such as cancer, diabetics, renal diseases, among others, which has increased the demand for personalized medicines.
  • The Global Glycobiology Market is segmented based on type of enzyme, type of kit, application, end-user, company and region.
  • Regionally, the glycobiology market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa.

The Latest in Glycan Analysis, Agilent Presents - Biopharma Workflow Solutions Virtual Symposium: Advances in Glycan and Sialic Acid Analysis, September 22, 2020

Retrieved on: 
Monday, September 21, 2020

SANTA CLARA, Calif., Sept. 21, 2020 /PRNewswire-PRWeb/ -- Agilent Technologies , a global leader in life science, diagnostics, and analytical laboratory technologies, to host Agilent Biopharma Workflow Solutions Virtual Symposium: Advances in Glycan and Sialic Acid Analysis, on September 22, 2020.

Key Points: 
  • SANTA CLARA, Calif., Sept. 21, 2020 /PRNewswire-PRWeb/ -- Agilent Technologies , a global leader in life science, diagnostics, and analytical laboratory technologies, to host Agilent Biopharma Workflow Solutions Virtual Symposium: Advances in Glycan and Sialic Acid Analysis, on September 22, 2020.
  • During the virtual conference, Agilent will offer a complete portfolio of samples to answers solutions to allow you to characterize released N-glycans, glycopeptides and intact glycoproteins efficiently and with confidence.
  • The Agilent Biopharma Workflow Solutions Virtual Symposium: Advances in Glycan and Sialic Acid Analysis will feature seven speakers such as Christopher Colangelo, PhD, MBA, Biopharma Business Development Leader, Rebecca Glaskin, Application Scientist, Agilent Technologies, David Wong, PhD, Sr.
  • Applications Scientist - LC/MS Solution, MSD Division, Agilent Technologies, and more to learn how to optimize and streamline glycan analysis.

Glycobiology Market Is Expected to Expand at An Impressive CAGR of Nearly 13% From 2020 To 2030

Retrieved on: 
Tuesday, September 1, 2020

The Global Glycobiology Market is Expected To Expand At An Impressive CAGR Of Nearly 13% From 2020 To 2030, And Reach A Valuation Of Around US$ 3.5 Bn By The End Of 2030, according to a new report by Persistence Market Research (PMR).

Key Points: 
  • The Global Glycobiology Market is Expected To Expand At An Impressive CAGR Of Nearly 13% From 2020 To 2030, And Reach A Valuation Of Around US$ 3.5 Bn By The End Of 2030, according to a new report by Persistence Market Research (PMR).
  • Due to high adoption of enzymes to conduct various research initiatives, this segment is expected to witness high incremental opportunity, globally.
  • North America will lead the growth of the global glycobiology market through 2030, followed by the market in Europe.
  • Popular Research Reports by PMR:
    Cervical Total Disc Replacement Market: https://www.persistencemarketresearch.com/market-research/cervical-total...
    Persistence Market Research (PMR) is a third-platform research firm.

Glycobiology Market Is Expected to Expand at An Impressive CAGR of Nearly 13% From 2020 To 2030

Retrieved on: 
Tuesday, September 1, 2020

The Global Glycobiology Market is Expected To Expand At An Impressive CAGR Of Nearly 13% From 2020 To 2030, And Reach A Valuation Of Around US$ 3.5 Bn By The End Of 2030, according to a new report by Persistence Market Research (PMR).

Key Points: 
  • The Global Glycobiology Market is Expected To Expand At An Impressive CAGR Of Nearly 13% From 2020 To 2030, And Reach A Valuation Of Around US$ 3.5 Bn By The End Of 2030, according to a new report by Persistence Market Research (PMR).
  • Due to high adoption of enzymes to conduct various research initiatives, this segment is expected to witness high incremental opportunity, globally.
  • North America will lead the growth of the global glycobiology market through 2030, followed by the market in Europe.
  • Popular Research Reports by PMR:
    Cervical Total Disc Replacement Market: https://www.persistencemarketresearch.com/market-research/cervical-total...
    Persistence Market Research (PMR) is a third-platform research firm.

SCIEX launches SCIEX Empower Driver version 1.3 for direct control of PA 800 Plus Pharmaceutical Analysis System

Retrieved on: 
Tuesday, May 19, 2020

SCIEX , a global leader in life science analytical technologies, announced today the launch of its much anticipated SCIEX Empower Driver version 1.3, a software interface that gives users direct control of their PA 800 Plus instrument in the Waters Empower 3 Chromatography Data System.

Key Points: 
  • SCIEX , a global leader in life science analytical technologies, announced today the launch of its much anticipated SCIEX Empower Driver version 1.3, a software interface that gives users direct control of their PA 800 Plus instrument in the Waters Empower 3 Chromatography Data System.
  • Long considered the gold standard for biologic characterization, the SCIEX PA 800 Plus has been routinely interfaced to Empower using the Waters Empower Driver 1.2.1.
  • The new SCIEX Empower Driver v1.3 expands on the capability and flexibility of the 1.2.1 driver including validated methods for CE SDS, cIEF and glycan applications along with full system qualification through Empower.
  • By providing our customers with the ability to interface and control the PA 800 Plus in Empower, we allow them to simplify implementation of the PA 800 Plus in QC while meeting data security and management requirements.